Sort
64,565 grants matching “drug discovery”
Discovery and development of GPR3 agonists for nicotine cessation
$866,733Elaine Arrington Gay · Research Triangle Institute · R01 · FY2024 · DA
Genetic Susceptibility To Carcinogens and Toxicants
$866,717Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Second Generation Small Molecule Inhibitors of Botulinum Neurotoxins
$866,638Sina Bavari · Geneva Foundation · U01 · FY2010 · AI
The Future of Genomics Medicine in Patient Care: Contributions from CHOP
$866,464Hakon Hakonarson · Children'S Hosp Of Philadelphia · U01 · FY2019 · HG
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
$866,441Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$866,362Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Development and Testing of New Computational Methods for Ligand Discovery and Mechanism
$866,203Brian K. Shoichet · University Of California, San Francisco · R35 · FY2018 · GM
PREVENTABLE Biorepository and Laboratory
$866,197Laura Kristin Newby · Duke University · U19 · FY2022 · AG
Closing the Gaps on Buruli Ulcer Diagnosis, Treatment, and Prevention
$866,149Eric L Nuermberger · Johns Hopkins University · R01 · FY2019 · AI
FACULTY DEVELOPMENT
$866,145Robert P Dottin · Hunter College · G12 · FY2011 · RR
Lead optimization of novel CRFBP-CRFR2 complex modulators for alcohol use disorder
$865,843Douglas J Sheffler · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · AA
Controlling Neuropilin-2 Signaling to Improve Lymphatic Function
$865,694Diane Renee Bielenberg · Boston Children'S Hospital · R01 · FY2025 · HL
Microfluidics Array Based Sorting, Isolation, and RNA Analysis in Single Extracellular V csicles
$865,616Eduardo Reategui · Ohio State University · UH3 · FY2022 · TR
GENETICS OF ADOLESCENT ANTISOCIAL DRUG DEPENDENCE
$865,566University Of Colorado Denver · R01 · FY2005 · DA
Investigational new drug enabling studies for the development of a topical fixed dose combination drug product to treat actinic keratosis and prevent cutaneous squamous cell carcinoma.
$865,361Andrew B Mahon · Phd Skin Care Llc · R44 · FY2022 · AR
Investigational new drug enabling studies for the development of a topical fixed dose combination drug product to treat actinic keratosis and prevent cutaneous squamous cell carcinoma.
$865,339Andrew B Mahon · Phd Skin Care Llc · R44 · FY2023 · AR
Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics with Tuba-seq - a Novel, Highly Scalable and Quantitative Preclinical Experimental Oncology Platform
$865,070Ian Paul Winters · D2g Oncology, Inc. · R44 · FY2021 · CA
Human pluripotent stem cells
$865,069Pamela Robey · National Institute Of Neurological Disorders And Stroke · ZIC · FY2021 · NS
Cancer Center Support Grant
$865,000Steven Terry Rosen · Beckman Research Institute/City Of Hope · P30 · FY2018 · CA
Probing Neuropsychiatric Diseases Using Targeted Epigenome and Genome Engineering
$865,000Feng Zhang · Broad Institute, Inc. · DP1 · FY2014 · MH
Probing Neuropsychiatric Diseases Using Targeted Epigenome and Genome Engineering
$865,000Feng Zhang · Broad Institute, Inc. · DP1 · FY2012 · MH
Probing Neuropsychiatric Diseases Using Targeted Epigenome and Genome Engineering
$865,000Feng Zhang · Broad Institute, Inc. · DP1 · FY2015 · MH
MegaTrans â human transporter machine learning models
$864,767Sean Ekins · Collaborations Pharmaceuticals, Inc. · R42 · FY2023 · GM
MegaTrans â human transporter machine learning models
$864,767Sean Ekins · Collaborations Pharmaceuticals, Inc. · R42 · FY2022 · GM
Core C Pharmacology
$864,677Veronique Dartois · Hackensack University Medical Center · U19 · FY2022 · AI